Lyudmila Bazhenova

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova et al. · Molecular Cancer Therapeutics · 2017 · 2.4K citations · Full text

Medicine, Immunology, Oncology +17

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares et al. · The Lancet Oncology · 2019 · 1.7K citations · Full text

Medicine, Oncology, Metastasis +9

Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS ^G12C </i> Mutation

Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2022 · 984 citations · Full text

Medicine, Oncology, Pharmacology +15

Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer

Bob T. Li, Egbert F. Smit, Yasushi Goto et al. · New England Journal of Medicine · 2021 · 980 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer

Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan et al. · New England Journal of Medicine · 2020 · 836 citations · Full text

Medicine, Oncology, Pharmacotherapy +13